期刊名称：DRUGS OF THE FUTURE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
A leading publication in the field of medicinal chemistry since its introduction in 1976.
Comprehensive drug monographs
provide product information on new compounds under development, including synthesis and corresponding schemes, pharmacological actions, pharmacokinetics and metabolism, toxicology, clinical studies and references.
Monthly information updates
provide the most recent information on drugs whose monographs were published in the same-numbered issues of past volumes, extending coverage up to the drug's marketing.
Minireviews
highlight new therapeutic approaches for the treatment of disease. Compounds currently under development and those in clinical use are presented and their chemical structures compared.
CIPS (Correlates in Pharmacostructures) and Enzyme Inhibitors
review articles are comprehensive surveys describing recent developments in topical fields of drug research and development in which chemical, biochemical, pharmacological and clinical aspects are discussed.
The journal's comprehensive indexes include a yearly pharmacostructural index and a cumulative formula index and cumulative general index of names from 1976 to the present.
Subscription Information:
Monthly publication (12 regular issues plus annual index issue)
ISSN: 0377-8282
Back volumes available (1986-1997)
Drugs of the Future is also available as a database in several electronic formats:
CIPSLINE
A series of structural databases of compounds appearing in the Drug Data Report and Drugs of the Future journals. More than 30,000 substructure-searchable compounds covered in 11 editions classified by therapeutic category. For use with MDL Information Systems, Inc.'s popular ISIS?Base and ChemBase?software for PC? ,Macintosh?and Silicon Graphics, Inc. computers.
ONLINE SERVICES
The Drugs of the Future database can be consulted online on Dialog (File 453) and DataStar (File PRFU).
Drugs of the Future - Current Issue
 A leading publication in the field of medicinal chemistry since its introduction in 1976. Comprehensive drug monographs provide product information on new compounds, including synthesis, pharmacological action, pharmacokinetics and metabolism, toxicology and clinical studies. Monthly information updates provide the most recent information on compounds published in past volumes. Review articles highlight recent developments in topical fields of drug research and development in which chemical, biochemical, pharmacological and clinical aspects are discussed.
 Drugs of the Future - Advanced Publication
 With the goal of disseminating its content as quickly as possible, Drugs of the Future now posts articles on its World Wide Web site in advance of publication in the print journal.
An article is posted online after it has been accepted for publication in the journal. When print issues are assembled, articles that have been posted since the previous issue will be assigned to the current issue. All articles will appear in a print issue as well as on the World Wide Web site and will be posted on the Advanced Publication page prior to assignment to a particular print issue.
Instructions to Authors
Articles published in Drugs of the Future are solicited by the Editor. Nonetheless, proposals for articles are welcome. Authors who wish to submit an article to the journal should first contact the Editor with their proposal and an outline for prior approval. Proposals and outlines may also be sent to members of the Editorial Board.
Submission of Manuscripts
The original and one print copy of the manuscript, figures, illustrations and tables should be sent to Prous Science, Editorial Department, Drugs of the Future, P.O. Box 540, 08080 Barcelona, Spain or Provenza 388, 08025 Barcelona, Spain (street address). Authors are highly encouraged to submit manuscripts on diskette or by e-mail (see below).
Preparation of Manuscripts
Manuscripts should be typed, double-spaced on one side of 8-1/2" x 11" or DIN A4 paper with ample margins on all sides. The manuscript should be logically divided into sections and subsections as appropriate. For monographs, the following sections (when applicable) should be included: Synthesis, Description, Introduction, Pharmacological Actions, Pharmacokinetics and Metabolism, Toxicology, Clinical Studies, Manufacturer or Source and References.
The cover page should contain the names, affiliations and addresses of all the authors, and the name, mailing address, telephone, fax number and e-mail address for the corresponding author.
Manuscripts should be printed with a good quality printer with black ink. Pages should be printed with enough quality as to allow double photocopying retaining readability. Do not use sans-serif fonts (Helvetica, Universe, Symbol). Use Times Roman sizes 10 to 12.
Do not right justify and avoid italics, boldface, underlining, super- and subscript, different type sizes and graphic types. Do not use non-standard or graphic characters. Spell out Greek letters (alpha, beta, etc.). Do not hyphenate words at the end of lines, use only mandatory hyphens.
Avoid page caps and foots. Do not number pages in the front; hand-mark pages in the back with the page number and the name of the author.
Figures
Figures should appear each on a separate sheet and need to be of the highest possible quality for reproduction. Figures should contain on the reverse side the corresponding author's last name, figure number (Arabic numerals) and an arrow indicating the top. Legends for all the figures should by typed on a separate sheet. Electronic versions of figures should be sent as BMP, WMF, TIF or GIF files.
Tables
Should be typed double-spaced, each on a separate sheet and with a suitable caption at the top of each table. Tables should be grouped and placed in order after the References.
References
The accuracy of all references cited is the responsibility of the author. The references should be parenthesized and numbered consecutively in the text. Journal titles should be abbreviated without periods as in Index Medicus. When there are 7 or more authors, use only the first 3, followed by et al. References should be cited in the Reference section (typed, double-spaced) as follows:
Journal citations
1. Fromtling, R.A. and Abruzzo, G.K. Chemiluminescence as a tool for the evaluation of antimicrobial agents: A review. Meth Find Exp Clin Pharmacol 1985, 7: 493-500.
Book citations
2. Klebanoff, S.J. Oxygen-dependent cytotoxic mechanisms of phagocytes. In: Advances in Host Defense Mechanisms, Vol. 1. Phagocytic Cells. J.I. Gaillin and A.S. Fauci (Eds.). Raven Press: New York 1982, 111-162.
Abstract citations
3. Gip, L. The effect of subinhibitory concentrations of bifonazole on the morphology of Trichophyton rubrum. IXth Int Cong Int Soc Human Animal Mycol (May 19-24, Atlanta) 1985, Abst. R9-2.
Drug Names, Abbreviations and Measurements
Generic drug names according to Rec INN or USAN should be used. Abbreviations should be defined the first time mentioned and should be standard. Measurements should be expressed in standard international units.
Proofs
Page proofs will be sent to the corresponding author for final corrections and approval before publication. Please return proofs within 5 days of receipt unless otherwise advised.
Reprints
Twenty-five reprints will be provided to senior authors free of charge. Additional copies in quantities of 100 can be purchased at prices shown on the reprint order form which is sent with the page proofs.
Copyright Responsibility
Authors must not incorporate copyrighted material without written permission from the copyright holder. It is the sole responsibility of the authors to secure such permission. The fact that such permission has been granted should be acknowledged in the manuscript. Copies of letters authorizing the use of copyrighted material should be forwarded to the editor at manuscript submittal.
Electronic Submission
Diskette
The final hard copy of the manuscript and version on diskette must be the same. If they differ, the hard copy will be used.
Forward the files on a 3 1/2" HD (1.44 MB) diskette formatted for use on a PC. Save the "text" files in one of the following word-processing formats: WordPerfect for DOS or Microsoft Word for Windows. If the files are submitted on a Macintosh diskette, the only acceptable word-processing format is Word. Clearly label the diskette with the name of the document(s), the format in which they have been saved and the diskette type (PC or Mac).
Whenever possible, electronic versions of figures should be sent, preferably as BMP, WMF, TIF or GIF files.
The diskette must be accompanied by one print copy of the article with original figures and tables and sent by airmail or courier service.
Package the diskette so as to avoid damage in transit and mark the envelope: "Magnetic media ?Do not x-ray."
E-mail
Save the document(s) in one of the above-mentioned formats and mail to journals@prous.com. Send an accompanying message advising the document length (X words plus Y references + Z tables + N figures) and giving the name of the document(s), the format in which created and the format in which saved for sending.
If transmission does not work, you will be advised to send the manuscript by airmail or courier service.
Editorial Board
Address all correspondence to:
Editorial Department
Drugs of the Future
Prous Science
P.O. Box 540
08080 Barcelona
Spain
Tel: +34 93 459-2220
Fax: +34 93 458-1535
e-mail: journals@prous.com
| 
刊名字顺( Alphabetical List of Journals):
返回页首 